.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Fuji
Teva
Express Scripts
Colorcon
Mallinckrodt
Harvard Business School
QuintilesIMS
Farmers Insurance
Julphar

Generated: September 23, 2017

DrugPatentWatch Database Preview

CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Cardene In 0.86% Sodium Chloride In Plastic Container, and when can generic versions of Cardene In 0.86% Sodium Chloride In Plastic Container launch?

Cardene In 0.86% Sodium Chloride In Plastic Container is a drug marketed by Chiesi Usa Inc and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-three patent family members in eleven countries.

The generic ingredient in CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

Summary for Tradename: CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER

Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list44
Clinical Trials: see list3,026
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-003Jul 31, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Chiesi Usa Inc
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-003Jul 31, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Chiesi Usa Inc
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-003Jul 31, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Chiesi Usa Inc
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-003Jul 31, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER

Drugname Dosage Strength RLD Submissiondate
nicardipine hydrochlorideInjection0.1 mg/mL, 200 mL and0.2mg/mL, 200 mLCardene in 0.86% Sodium Chloride in plastic container6/20/2013

Non-Orange Book Patents for Tradename: CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,659,290Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions► Subscribe
9,549,994Compositions of nicardipine and sulfoalkylated .beta.-cyclodextrin► Subscribe
9,370,586Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER

Country Document Number Estimated Expiration
Mexico2008013407► Subscribe
Mexico2008013405► Subscribe
Australia2007240820► Subscribe
Japan2009534409► Subscribe
Canada2649779► Subscribe
Canada2650922► Subscribe
Israel194799► Subscribe
Canada2895102► Subscribe
South Korea20090040258► Subscribe
European Patent Office2012788► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Chinese Patent Office
Moodys
US Army
Accenture
Mallinckrodt
Baxter
AstraZeneca
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot